Study suggests semaglutide aids smoking cessation in type 2 diabetes patients.

Semaglutide, a weight-loss and diabetes drug like Ozempic and Wegovy, may potentially assist in smoking cessation, according to a study published in the Annals of Internal Medicine. The study found that type 2 diabetes patients using semaglutide medications had fewer smoking-related medical interactions and required less assistance to quit smoking compared to patients on other diabetes medications. Further clinical trials are needed to evaluate semaglutide's potential for treating tobacco use disorder.